Arbutus Biopharma Corp Uncategorized Contracts & Agreements
33 Contracts & Agreements
- Option Agreement, dated July 10, 2023, by and between Arbutus Biopharma Corporation and J. Christopher Naftzger (Filed With SEC on August 3, 2023)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2023)
- Form of Arbutus Biopharma Corporation Indemnity Agreement (Filed With SEC on March 3, 2022)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 3, 2022)
- Amendment No. 3 to the Open Market Sale AgreementSM, dated March 4, 2021, by and between Arbutus Biopharma Corporation and Jefferies LLC (Filed With SEC on March 4, 2021)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 4, 2021)
- Amendment No. 2 to the Open Market Sale Agreement (Filed With SEC on August 7, 2020)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 5, 2020)
- Offer Letter, dated August 8, 2019, by and between Arbutus Biopharma Corporation and Andrew Cheng (Filed With SEC on November 6, 2019)
- Form of Arbutus Biopharma Corporation Indemnity Agreement (Filed With SEC on November 6, 2019)
- Option Agreement, dated June 24, by and between Arbutus Biopharma, Inc. and William H. Collier (Filed With SEC on August 5, 2019)
- Form of Arbutus Biopharma Corporation Option Agreement (Filed With SEC on August 5, 2019)
- Form of Indemnity Agreement (Filed With SEC on June 18, 2019)
- Form of Indemnity Agreement (re with initial Agreement by reference to Exhibit 4.15 to the Registrants Annual Report on Form 20-F for the year ended December 31, 2010 filed with... (Filed With SEC on March 7, 2019)
- Open Market Sale AgreementSM, dated December 20, 2018, by and between Arbutus Biopharma Corporation and Jefferies LLC (Filed With SEC on December 20, 2018)
- Indemnity Agreement between Arbutus Biophrama Corporation and Koert VandenEnden, dated February 16, 2018 (Filed With SEC on March 16, 2018)
- DEPARTMENT OF THE ARMY U.S. ARMY CONTRACTING COMMAND - ABERDEEN PROVING GROUND NATICK CONTRACTING DIVISION 1 KANSAS STREET NATICK, MA ###-###-#### October 1, 2015 (Filed With SEC on March 22, 2017)
- NameAward dateGranted #Exercise priceExpiry DateVesting termsMike AbramsDecember 9, 20085,000 $1.80 8-Dec-18ImmediateMike AbramsJanuary 28, 20105,000 $3.85 27-Jan-20ImmediateMike... (Filed With SEC on November 3, 2016)
- Award dateGranted #Exercise priceExpiry DateVesting termsOptions vestedAugust 12, 201350,000CAD$16.40 August 11, 20231/4 immed. 1/4 on 1st, 2nd & 3rdanniversary50,000February 5,... (Filed With SEC on November 3, 2016)
- ACKNOWLEDGMENT OF COMMENCEMENT DATE (Filed With SEC on November 3, 2016)
- Amending Agreement, dated as of November 2,2015, among Arbutus Biopharma Corporation, Roivant Sciences Ltd., Patrick T. Higgins, Michael J. McElhaugh, Michael J. Sofia and Bryce... (Filed With SEC on November 5, 2015)
- Letter Agreement between OnCore Biopharma, Inc. and Cytos Biotechnology AG, effective July 16, 2015 (Filed With SEC on November 5, 2015)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT (Filed With SEC on August 7, 2015)
- AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT (Filed With SEC on August 7, 2015)
- 2,125,000 Common Shares TEKMIRA PHARMACEUTICALS CORPORATION (incorporated under the Business Corporations Act (BritishColumbia)) UNDERWRITINGAGREEMENT (Filed With SEC on March 13, 2015)
- 3,750,000 Common Shares TEKMIRA PHARMACEUTICALS CORPORATION (incorporatedundertheBusinessCorporationsAct(BritishColumbia)) UNDERWRITINGAGREEMENT (Filed With SEC on March 13, 2015)
- 30-105-04 (Filed With SEC on March 13, 2015)
- EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on March 13, 2015)
- EMPLOYMENTAGREEMENT (Filed With SEC on March 13, 2015)
